COGT - Cogent Biosciences down 7% on pricing $150M offering
2023-06-07 01:58:04 ET
- Biotechnology company, Cogent Biosciences ( NASDAQ: COGT ) stock price declines 7% as it prices previously announced underwritten public offering of 12.5M shares at $12.00 per share.
- Gross proceeds are expected to be ~$150M, upsized from $125M.
- Underwriters have a 30-day option to purchase up to an additional ~1.88M shares.
- The offering is expected to close on or about June 9, 2023.
- Net proceeds will be used for development, regulatory and commercial preparation activities relating to bezuclastinib and other product candidates, as well as for working capital and general corporate purposes.
For further details see:
Cogent Biosciences down 7% on pricing $150M offering